Balyasny Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.65M | Buy |
|
|||||
|
2024
Q4 | $1.14M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $4.66M | Sell |
|
|||||
|
2023
Q2 | $33.5M | Sell |
|
|||||
|
2023
Q1 | $36.9M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $501K | Sell |
|
|||||
|
2022
Q2 | $636K | Sell |
|
|||||
|
2022
Q1 | $8.09M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $7.14M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $6.5M | Sell |
|
|||||
|
2020
Q4 | $10.5M | Buy |
|
|||||
|
2020
Q3 | $2.56M | Buy |
|
|||||
|
2020
Q2 | $1.66M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $948K | Sell |
|
|||||
|
2018
Q3 | $1.92M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $749K | Buy |
|
|||||
|
2017
Q4 | $736K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $215K | Buy |
|
|||||
|
2014
Q2 | – | Hold |
|
|||||
|
2014
Q1 | – | Hold |
|
|||||
|
2013
Q4 | – | Hold |
|
|||||
|
2013
Q3 | – | Hold |
|